Jeffery Auletta
Pediatric Hematology-Oncology · Columbus, OHNPI 1649298365
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,750 of the $7,885 with a category attached, or 98.3%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 98.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2023 at $5,250 and has fallen 99.7% since, to $17 in 2025.
Across 6 payments — averaging $1314.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- AbbVie$118
- Medexus Pharma, Inc.$17
Across 4 payments — averaging $175,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$600K
- Incyte Corporation$100K
What the payments were for
- Consulting fees$7,75098%
- Food & beverage$170%
- Education$1181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $7,750 |
| AbbVie | 2 | $118 |
| Medexus Pharma, Inc. | 1 | $17 |
How this compares
$7,885 in reported general payments places this provider in the 65th percentile of 143 pediatric hematology-oncology providers in Ohio.
Other pediatric hematology-oncology in Columbus
- Amy DunnColumbus$129K
- Bryce KerlinColumbus$123K
- Anthony VillellaColumbus$66K
- Sarah ObrienColumbus$30K
- Timothy CripeColumbus$26K
- Dean LeeColumbus$20K
- Ryuma TanakaColumbus$16K
- Nilay ShahColumbus$16K
- Melissa RoseColumbus$15K
- Rolla Abu ArjaColumbus$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.